3 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
| 1 | 33480647 | Augmented Antitumor Activity for Novel Dual PI3K/BDR4 Inhibitors, SF2523 and SF1126 in Ewing Sarcoma. | 2021 Apr 1 | 1 |
| 2 | 28881723 | Association of high microvessel αvβ3 and low PTEN with poor outcome in stage 3 neuroblastoma: rationale for using first in class dual PI3K/BRD4 inhibitor, SF1126. | 2017 Aug 8 | 2 |
| 3 | 27496136 | Single Agent and Synergistic Activity of the "First-in-Class" Dual PI3K/BRD4 Inhibitor SF1126 with Sorafenib in Hepatocellular Carcinoma. | 2016 Nov | 4 |